FINWIRES · TerminalLIVE
FINWIRES

Morgan Stanley Downgrades Novo Nordisk to Underweight From Equalweight, Price Target is $40

By

Novo Nordisk A/S (NVO) has an average rating of hold and mean price target of $44.50, according to analysts polled by FactSet.

What else is happening in Research?